BACKGROUND: Cardioskeletal myopathy is thought to contribute to exercise intolerance, and reduced quality of life (QOL) in Barth syndrome (BTHS). The objectives of this study were to examine: (1) skeletal muscle strength/performance in adolescents and young adults with BTHS and (2) the safety, feasibility, and initial efficacy of 12 weeks of progressive resistance exercise training (RET) on muscle strength, mass, and performance, bone mineral density, exercise tolerance, cardiac function, and QOL in individuals with BTHS. METHODS: Individuals with BTHS (n = 9, 23 ± 6 years), and age-, sex-, and activity level-matched unaffected Controls (n = 7, 26 ± 5 years) underwent baseline testing to assess muscle performance, exercise capacity, cardiac structure and function, body composition, and health-related QOL. Subsequently, n = 3 participants with BTHS performed 12 weeks of supervised RET (60 min per session, 3 sessions/week). All testing was repeated post-RET. RESULTS: BTHS had lower strength and lean muscle mass compared to Controls (all p < 0.05). BTHS also had diminished lower extremity, upper extremity, thoracic spine, lumbar spine, and pelvic bone mineral density (all p < 0.05) and reduced exercise capacity (p < 0.001) compared to Controls. RET was well-tolerated and attended, was not associated with any adverse events, and significantly increased muscle strength (p < 0.05). CONCLUSIONS: Individuals with BTHS demonstrate reduced muscle strength and mass, bone mineral density, and exercise capacity. RET appears safe and well-tolerated in BTHS and promotes increased muscle strength. Larger studies are needed to confirm these improvements and to fully determine the effects of RET in individuals with BTHS.
BACKGROUND:Cardioskeletal myopathy is thought to contribute to exercise intolerance, and reduced quality of life (QOL) in Barth syndrome (BTHS). The objectives of this study were to examine: (1) skeletal muscle strength/performance in adolescents and young adults with BTHS and (2) the safety, feasibility, and initial efficacy of 12 weeks of progressive resistance exercise training (RET) on muscle strength, mass, and performance, bone mineral density, exercise tolerance, cardiac function, and QOL in individuals with BTHS. METHODS: Individuals with BTHS (n = 9, 23 ± 6 years), and age-, sex-, and activity level-matched unaffected Controls (n = 7, 26 ± 5 years) underwent baseline testing to assess muscle performance, exercise capacity, cardiac structure and function, body composition, and health-related QOL. Subsequently, n = 3 participants with BTHS performed 12 weeks of supervised RET (60 min per session, 3 sessions/week). All testing was repeated post-RET. RESULTS:BTHS had lower strength and lean muscle mass compared to Controls (all p < 0.05). BTHS also had diminished lower extremity, upper extremity, thoracic spine, lumbar spine, and pelvic bone mineral density (all p < 0.05) and reduced exercise capacity (p < 0.001) compared to Controls. RET was well-tolerated and attended, was not associated with any adverse events, and significantly increased muscle strength (p < 0.05). CONCLUSIONS: Individuals with BTHS demonstrate reduced muscle strength and mass, bone mineral density, and exercise capacity. RET appears safe and well-tolerated in BTHS and promotes increased muscle strength. Larger studies are needed to confirm these improvements and to fully determine the effects of RET in individuals with BTHS.
Authors: D Harrington; S D Anker; T P Chua; K M Webb-Peploe; P P Ponikowski; P A Poole-Wilson; A J Coats Journal: J Am Coll Cardiol Date: 1997-12 Impact factor: 24.094
Authors: Carolyn T Spencer; Barry J Byrne; Randall M Bryant; Renee Margossian; Melissa Maisenbacher; Petar Breitenger; Paul B Benni; Sharon Redfearn; Edward Marcus; W Todd Cade Journal: Am J Physiol Heart Circ Physiol Date: 2011-08-26 Impact factor: 4.733
Authors: A Menkes; S Mazel; R A Redmond; K Koffler; C R Libanati; C M Gundberg; T M Zizic; J M Hagberg; R E Pratley; B F Hurley Journal: J Appl Physiol (1985) Date: 1993-05
Authors: Ian Janssen; Richard N Baumgartner; Robert Ross; Irwin H Rosenberg; Ronenn Roubenoff Journal: Am J Epidemiol Date: 2004-02-15 Impact factor: 4.897
Authors: S Heshka; A Ruggiero; G A Bray; J Foreyt; S E Kahn; C E Lewis; M Saad; A V Schwartz Journal: Int J Obes (Lond) Date: 2008-01-29 Impact factor: 5.095
Authors: Adil Bashir; Kathryn L Bohnert; Dominic N Reeds; Linda R Peterson; Adam J Bittel; Lisa de Las Fuentes; Christina A Pacak; Barry J Byrne; W Todd Cade Journal: Physiol Rep Date: 2017-02
Authors: Sarah L N Clarke; Ann Bowron; Iris L Gonzalez; Sarah J Groves; Ruth Newbury-Ecob; Nicol Clayton; Robin P Martin; Beverly Tsai-Goodman; Vanessa Garratt; Michael Ashworth; Valerie M Bowen; Katherine R McCurdy; Michaela K Damin; Carolyn T Spencer; Matthew J Toth; Richard I Kelley; Colin G Steward Journal: Orphanet J Rare Dis Date: 2013-02-12 Impact factor: 4.123
Authors: Kathryn L Bohnert; Grace Ditzenberger; Adam J Bittel; Lisa de Las Fuentes; Manuela Corti; Christina A Pacak; Carolyn Taylor; Barry J Byrne; Dominic N Reeds; W Todd Cade Journal: JIMD Rep Date: 2021-08-09
Authors: Tyler Ralph-Epps; Chisom J Onu; Linh Vo; Michael W Schmidtke; Anh Le; Miriam L Greenberg Journal: Front Physiol Date: 2021-10-28 Impact factor: 4.566